Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful treatment of chronic tophaceous gout with infliximab (Remicade).

Literature DB >> 15933855

Successful treatment of chronic tophaceous gout with infliximab (Remicade).

Christoph Fiehn¹, Martin Zeier.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2005 PMID： 15933855 DOI： 10.1007/s00296-005-0617-7

Source DB: PubMed Journal: Rheumatol Int ISSN： 0172-8172 Impact factor: 2.631

× No keyword cloud information.

7 in total

Review 1. Clinical practice. Gout.

Authors: Robert A Terkeltaub
Journal: N Engl J Med Date: 2003-10-23 Impact factor: 91.245

2. Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option.

Authors: A K Tausche; K Richter; A Grässler; S Hänsel; B Roch; H E Schröder
Journal: Ann Rheum Dis Date: 2004-10 Impact factor: 19.103

Review 3. Systemic steroid therapy for acute gout: a clinical trial and review of the literature.

Authors: G D Groff; W A Franck; D A Raddatz
Journal: Semin Arthritis Rheum Date: 1990-06 Impact factor: 5.532

4. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout?

Authors: J Li-Yu; G Clayburne; M Sieck; A Beutler; M Rull; E Eisner; H R Schumacher
Journal: J Rheumatol Date: 2001-03 Impact factor: 4.666

5. Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution.

Authors: F S di Giovine; S E Malawista; E Thornton; G W Duff
Journal: J Clin Invest Date: 1991-04 Impact factor: 14.808

6. Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy.

Authors: Jacques-Eric Gottenberg; Florence Merle-Vincent; Fabrice Bentaberry; Yannick Allanore; Francis Berenbaum; Bruno Fautrel; Bernard Combe; Antoine Durbach; Jean Sibilia; Maxime Dougados; Xavier Mariette
Journal: Arthritis Rheum Date: 2003-07

7. Efficacy of colchicine prophylaxis in gout. Prevention of recurrent gouty arthritis over a mean period of five years in 208 gouty subjects.

Authors: T F YU; A B GUTMAN
Journal: Ann Intern Med Date: 1961-08 Impact factor: 25.391

7 in total

9 in total

Review 1. Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors: C A Dinarello
Journal: J Intern Med Date: 2011-01 Impact factor: 8.989

2. How interleukin-1β induces gouty arthritis.

Authors: Charles A Dinarello
Journal: Arthritis Rheum Date: 2010-11

3. [Crystal-induced activation of the inflammasome: gout and pseudogout].

Authors: M Winzer; A-K Tausche; M Aringer
Journal: Z Rheumatol Date: 2009-11 Impact factor: 1.372

Review 4. Mechanisms of inflammation in gout.

Authors: Nathalie Busso; Alexander So
Journal: Arthritis Res Ther Date: 2010-04-26 Impact factor: 5.156

5. New and improved strategies for the treatment of gout.

Authors: Natalie Dubchak; Gerald F Falasca
Journal: Int J Nephrol Renovasc Dis Date: 2010-11-24

6. Mechanism Investigation of Wuwei Shexiang Pills on Gouty Arthritis via Network Pharmacology, Molecule Docking, and Pharmacological Verification.

Authors: Jirui Lang; Li Li; Shilong Chen; Yunyun Quan; Jing Yi; Jin Zeng; Yong Li; Junning Zhao; Zhujun Yin
Journal: Evid Based Complement Alternat Med Date: 2022-10-07 Impact factor: 2.650